PRICE T ROWE ASSOCIATES INC /MD/

Position in APGE — Apogee Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,484,883

-$64,734,220 QoQ

Shares Held

237,210

-79.2% QoQ

Ownership

0.313%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#55

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. APGE ranks #80 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,484,883	237,210	-79.2%	Shares	Sole	2026-08-14
2026-03-31	$96,219,103	1,143,152	-7.6%	Shares	Defined	2026-05-15
2025-12-31	$93,378,949	1,237,135	+64.8%	Shares	Sole	2026-02-17
2025-09-30	$29,818,517	750,529	-1.4%	Shares	Sole	2025-11-14
2025-06-30	$33,043,454	760,844	-7.4%	Shares	Sole	2025-08-14
2025-03-31	$30,704,315	821,850	-21.9%	Shares	Sole	2025-05-14
2024-12-31	$47,682,553	1,052,595	+38.8%	Shares	Sole	2025-02-14
2024-09-30	$44,529,677	758,081	-1.3%	Shares	Sole	2024-11-14
2024-06-30	$30,229,495	768,221	-34.4%	Shares	Defined	2024-08-14
2024-03-31	$77,768,229	1,170,327	+51.9%	Shares	Sole	2024-05-15
2023-12-31	$21,532,826	770,681	+25.1%	Shares	Sole	2024-02-16
2023-09-30	$13,119,734	615,950	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.